pharma · Calculus, Dental · Oral Malodor
Colgate Oral Pharmaceuticals
Colgate Oral Care
Colgate Oral Care is a pharma organization headquartered in AU. Primary therapeutic focus areas include Calculus, Dental, Oral Malodor. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s
AU HQ
TGA registrant Type
Company details
- Status
- Public
- HQ
- AU
- Programs
- 2
- Drugs
- 0
- Patents
- 0
0.454% stannous fluoride
Phase 3 · small molecule · Oral Malodor
0.454% stannous fluoride for Oral Malodor is a Phase 3 program (small_molecule) at Colgate Oral Care with 1 ClinicalTrials.gov record(s).
Internal code CRO-2017-10-OM-SNHW-THA-YPZ
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Colgate Oral Care
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Oral Malodor
- Status
- completed
- Trials
- 1